Sign In
Buy KVUE
$16.83
-0.490 (-2.83%)
At Close: Jun 03, 2026
3 Great Dividend Stocks You Can Buy for Less Than $50
08:10am, Friday, 15'th Sep 2023
Kroger's reasonable valuation offers much more upside than your traditional grocer. Rollins' top-notch profitability highlights its incredible track record of tuck-in acquisitions.
Better Buy: J&J vs. Kenvue
05:30am, Wednesday, 13'th Sep 2023
Johnson & Johnson recently spun off its consumer health unit into a new company called Kenvue. The consumer health segment weighed on J&J's growth, but it could progress successfully as an independent
Kenvue oversold, concerns priced in, says Deutsche
07:35am, Monday, 11'th Sep 2023
Kenvue Inc shares rose 2.5% in pre-market trading on Monday boosted by an upgrade by Deutsche Bank. The German investment bank has moved the firm, the consumer-health business spun-out of Johnson & Jo
J&J Spinoff Kenvue is the New Dividend Aristocrat on the Block
09:59am, Thursday, 07'th Sep 2023
You're familiar with its products, including Tylenol, Neutrogena, Listerine and Johnson's Baby Shampoo. Still, you may not be up to speed on Kenvue Inc. NYSE: KVUE and its status as a long-term divide
1 Brand-New Dividend Stock Income Investors Won't Want to Miss
09:05am, Thursday, 07'th Sep 2023
Kenvue, which was recently spun off from Johnson & Johnson, already pays an attractive dividend. The company supports that payout with a strong financial profile and durable business.
Is J&J a Buy After the Kenvue Separation?
06:00am, Wednesday, 06'th Sep 2023
J&J recently completed the spinoff of its consumer health business, letting go of star products that populate most of our medicine cabinets. But J&J's two other units, pharmaceuticals and medtech, act
Kenvue: Charting A Healthy Future In Consumer Health
03:38am, Wednesday, 06'th Sep 2023
Kenvue Incorporated is a leader in the consumer health industry with a large catalog of notable consumer brands. Kenvue has high brand recognition and market share in various sub-sectors of the health
Is This Incredible Dividend Stock Still a Buy Following Its Recent Split?
07:30am, Saturday, 02'nd Sep 2023
Johnson & Johnson refreshed its financial guidance following its split from Kenvue. The healthcare behemoth offset most of the financial impact of the split because the exchange offer lowered its shar
Johnson & Johnson Forecasts Double-Digit Earnings Growth After Kenvue Spin-Off
12:50pm, Wednesday, 30'th Aug 2023
Johnson & Johnson (JNJ) on Wednesday released its first earnings forecast as a standalone pharmaceutical and medical devices company, estimating double-digit growth in earnings this year.
Johnson & Johnson sets out new guidance after Kenvue split
07:42am, Wednesday, 30'th Aug 2023
Johnson & Johnson (NYSE:JNJ) has released new financial results for previous quarters that strip out the consumer-health unit that was recently hived off into a new company called Kenvue. J&J, which i
Johnson & Johnson Maintains Dividend After Kenvue Spinout
07:40am, Wednesday, 30'th Aug 2023
Johnson & Johnson maintains its quarterly dividend of $1.19 a share after spinning out consumer-health company Kenvue, although it lowers its earnings and sales projections.
J&J revises 2023 sales, profit outlook lower after Kenvue separation, will maintain dividend
06:50am, Wednesday, 30'th Aug 2023
Johnson & Johnson JNJ, +0.01% updated on Wednesday its 2023 financial guidance in the wake of the Kenvue Inc. KVUE, -0.48% separation that was completed last week. The drug maker now expects full-year
Options Bulls Pick Up on Blue-Chip's Split-Off
02:44pm, Monday, 28'th Aug 2023
Dow member Johnson & Johnson (JNJ) last week completed a split-off exchange offer of 1.53 billion shares of Kenvue Inc (NYSE:KVUE) worth roughly $40 billion.
J&J's Kenvue Exchange Offer Was a Big Win for the Little Guy
11:22am, Friday, 25'th Aug 2023
Small investors earned a nice payday of more than $1,000 if they tendered 99 shares of stock in the swap, which expired last week.
Johnson & Johnson: Kenvue Separation Won't Impact Dividends
01:20pm, Thursday, 24'th Aug 2023
Johnson & Johnson recently completed the Kenvue spinoff. We outline the impacts on its dividend payouts from this spinoff. I analyzed its dividend payout both using simple payout ratios and also using
